Abbvie Inc

NYSE:ABBV   10:47:20 AM EDT
142.46
+1.17 (+0.83%)
Other Pre-Announcement

Abbvie Says Qtrly Earnings Per Share $0.51; Qtrly Adjusted Earnings Per Share $3.37

Published: 07/29/2022 11:55 GMT
Abbvie Inc (ABBV) - Abbvie - Qtrly GAAP Earnings per Share $0.51 ; Qtrly Adjusted.
Earnings per Share $3.37.
Abbvie - Confirms 2022 Adjusted.
Diluted EPS Guidance Range of $13.78-$13.98.
Abbvie - Qtrly Net Revenues $14.58 Billion, Up 4.5% on a Reported Basis and Up 6.1% Operationally.
Abbvie - 2022 Adjusted.
Profit Guidance Includes Unfavorable Impact of $0.23/share Related Acquire Ipr&d and Milestones Expense Incurred Ytd.
Abbvie - Skyrizi & Rinvoq Are on Pace to Deliver About $7.5 Billion in Combined Annual Sales.
Abbvie - Qtrly Results Include Unfavorable Impact of $0.14/share Related to Acquired Ipr&d and Milestones Expense.
Abbvie - Qtrly Global Humira Net Revenues of $5.363 Billion, Up 5.8% on Reported Basis, Or Up 6.8% on Operational Basis.
Abbvie - Qtrly Global Skyrizi Net Revenues $1.252 Billion, Up 85.9% on a Reported Basis, Or Up 88.3% Operationally.
Abbvie - Qtrly Global Rinvoq Net Revenues $592 Million, Up 56.3% on Reported Basis, Up 60.7% Operationally.
Abbvie - Qtrly Global Net Revenues From Aesthetics Portfolio $1.371 Billion, Down 4.4% On Reported Basis, Or Down 2.1% Operationally.
Abbvie - in Quarter, Items Related to Litigation Matters Impacted Results by $2,203 Million Pre-tax.
Abbvie - in Quarter, Items Related to Litigation Matters Include Charges for Potential Litigation Settlement Involving Allergan's Past Sales of Opioid Products.
Q2 Earnings per Share View $3.31, Revenue View $14.64 Billion -- Refinitiv Ibes Data (analyst estimates).